Open Access

[Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways

  • Authors:
    • Xuerong Liu
    • Yan Wang
    • Jinglong Zhao
  • View Affiliations

  • Published online on: August 25, 2022     https://doi.org/10.3892/or.2022.8394
  • Article Number: 179
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2022
Volume 48 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu X, Wang Y and Zhao J: [Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Oncol Rep 48: 179, 2022
APA
Liu, X., Wang, Y., & Zhao, J. (2022). [Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Oncology Reports, 48, 179. https://doi.org/10.3892/or.2022.8394
MLA
Liu, X., Wang, Y., Zhao, J."[Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways". Oncology Reports 48.4 (2022): 179.
Chicago
Liu, X., Wang, Y., Zhao, J."[Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways". Oncology Reports 48, no. 4 (2022): 179. https://doi.org/10.3892/or.2022.8394